|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 12,97 USD | +0,46% |
|
-4,57% | -17,82% |
| 08/01 | Enanta Pharmaceuticals, Inc. geeft update over haar onderzoeks- en ontwikkelingsprogramma's | CI |
| 17/11 | Enanta Pharmaceuticals verkleint kwartaalverlies en ziet omzet stijgen | MT |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0,46% | -4,57% | -12,84% | +12,79% | -17,82% | +157,65% | -74,82% | -72,23% | -51,41% | 373 mln. | |
| -2,13% | -2,93% | +0,15% | +35,15% | -2,34% | +5,14% | +4,38% | +47,25% | +64,02% | 78,8 mld. | |
| -0,37% | +87,80% | +87,80% | +87,80% | +87,80% | +87,80% | +87,80% | +87,80% | - | 58,65 mld. | |
| +0,91% | +8,22% | +8,03% | -2,23% | +6,54% | +32,92% | +225,98% | +196,13% | +219,43% | 55,89 mld. | |
| -1,02% | +0,50% | -5,77% | -17,15% | +0,39% | -39,21% | -38,41% | -36,53% | +65,73% | 56,73 mld. | |
| -3,13% | -0,68% | +3,21% | +25,35% | +3,06% | +20,77% | -37,03% | -31,99% | -32,13% | 27,23 mld. | |
| -0,92% | -0,74% | +7,33% | +24,95% | +7,19% | +46,29% | +30,98% | +14,16% | +35,00% | 20,87 mld. | |
| -0,11% | +6,88% | +4,87% | -0,72% | +17,18% | +163,96% | +125,06% | -0,89% | - | 19,74 mld. | |
| +6,79% | +11,82% | +12,68% | +10,85% | +13,68% | +65,11% | +1.364,18% | +489,62% | +7.645,68% | 17,33 mld. | |
| +3,27% | +5,71% | +4,97% | +39,77% | +2,26% | +131,89% | +793,89% | +19,08% | - | 14,81 mld. | |
| -0,04% | -.--% | -.--% | -.--% | -.--% | +39,00% | +171,78% | +293,88% | +206,96% | 14,02 mld. | |
| +15,01% | +8,24% | +29,01% | +44,35% | +30,89% | +9,82% | -79,90% | -68,89% | - | 13,22 mld. | |
| +0,54% | +0,54% | +1,82% | +12,02% | +0,84% | +4,61% | +48,23% | +115,40% | +177,58% | 12,54 mld. | |
| -5,52% | -8,94% | +4,95% | +4,29% | -7,96% | -18,35% | -51,47% | -33,24% | -34,97% | 11,09 mld. | |
| -0,01% | +0,12% | +0,67% | +47,75% | +0,29% | +154,63% | +219,38% | +170,63% | - | 10,9 mld. | |
| +4,50% | +9,01% | +1,80% | +1,80% | +17,12% | +397,72% | +236,34% | +313,43% | +169,71% | 8,68 mld. | |
| -0,87% | +1,92% | +19,79% | +44,60% | -4,08% | +96,24% | +160,30% | +120,35% | +1.614,09% | 8,91 mld. | |
| -0,51% | +2,61% | -0,11% | -18,12% | +4,87% | -30,57% | -50,69% | -52,34% | - | 8,59 mld. | |
| -1,58% | -3,45% | +1,11% | -10,24% | +1,96% | +24,26% | -10,17% | -54,41% | -45,29% | 7,86 mld. | |
| -4,41% | -5,02% | -13,67% | +19,13% | -5,02% | +253,60% | +968,48% | +940,21% | +711,65% | 7,62 mld. | |
| Gemiddelde | +0,55% | +2,59% | +7,79% | +18,11% | +7,84% | +80,16% | +204,72% | +122,87% | +767,58% | 22,69 mld. | |
| Gewogen gemiddelde per kap. | -0,01% | +4,04% | +14,26% | +22,98% | +14,66% | +47,30% | +148,82% | +92,84% | +546,00% |
- Beurs
- Aandelen
- Koers ENTA
- Sector Enanta Pharmaceuticals, Inc.
Kies jouw editie
Alle financiële informatie op nationaal niveau
